# EC50 of Dexmedetomidine in Deep Brain Stimulation Implantation of Patients With Parkinson's Disease

> **NCT05376761** · PHASE4 · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 40 (estimated)

## Conditions studied

- PD - Parkinson's Disease

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT05376761
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-31
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05376761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05376761, "EC50 of Dexmedetomidine in Deep Brain Stimulation Implantation of Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05376761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*